AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced it will be exhibiting at the 9^th Annual MEDTEC IRELAND Medical Design and Manufacturing Exhibition and Conference, being held at the Radisson SAS Hotel in Galway, Ireland, from September 23-25, 2009. The Company will simultaneously launch the newest in an expanding line of innovative biomaterials focused on the product development needs of the medical device community.

Khristine Carroll, AdvanSource’s Vice President of Sales and Marketing, stated, “We are pleased to have the opportunity to initiate the first phase of our new material product launch, ChronoSil, a thermoplastic silicone polycarbonate urethane, while exhibiting at the Galway show. The ChronoSil product family maintains the inherent benefits of a polycarbonate-based urethane, including high pressure resistance, tensile-strength and superior chemical resistance combined with silicone’s industry-recognized advantages such as heightened elongation, superior elasticity and a low coefficient of friction. With many of the largest medical device companies actively manufacturing or otherwise represented in the country, we are confident this will be an exciting opportunity to showcase our newest product and an expanding line of advanced biomaterials and technologies. We encourage medical device professionals and the investment community to sign-up for the Exhibit at www.medtecireland.com and meet with us at this event.”

MEDTEC IRELAND is the largest event dedicated to industry professionals engaged in the design and manufacturing of medical devices in the country. Each year it offers over 900 visitors and over 100 exhibitors the benefit of being able to view the latest innovations and technologies that will form the basis for the next generation of medical devices. Representatives of the Company’s senior management and sales staff will be in attendance at booth 206.

About AdvanSource Biomaterials Corporation

AdvanSource Biomaterials Corporation manufactures advanced polymer materials which provide critical characteristics in the design and development of medical devices. The Company’s biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. AdvanSource’s business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. More information about AdvanSource is available at its website: www.advbiomaterials.com

Forward-Looking Statements

AdvanSource believes that this press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause results to differ materially from the forward-looking statements. For further information on such risks and uncertainties, you are encouraged to review AdvanSource’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended March 31, 2009 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2009. AdvanSource assumes no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.